Biosyent Inc. Tangible Net Worth Ratio
Biosyent Inc. tangible net worth ratio. Biosyent Inc. (RX) has a Tangible Net Worth Ratio of 87.6% as of September 2025. This metric is calculated by deducting intangible assets (CA$4.95 Million) from net assets (CA$39.90 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore RX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Biosyent Inc. (1997–2024)
Tangible net worth ratio of Biosyent Inc. from 1997 to 2024. This chart shows how Biosyent Inc.'s Tangible Net Worth Ratio has changed across 28 annual periods from 1997 to 2024. As of September 2025, the ratio stands at 87.6%, reflecting net assets of CA$39.90 Million with intangible assets of CA$4.95 Million CAD. Check RX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Biosyent Inc. Tangible Net Worth Ratio by Year (1997–2024)
Biosyent Inc. tangible net worth ratio by year from 1997 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Biosyent Inc. from 1997 to 2024, covering 28 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see RX stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CAD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.6% | CA$35.00 Million | CA$5.04 Million | CA$41.36 Million | ▼ -11.1 pp |
| 2023 | 96.7% | CA$34.76 Million | CA$1.15 Million | CA$41.53 Million | ▲ +0.3 pp |
| 2022 | 96.4% | CA$33.36 Million | CA$1.20 Million | CA$40.49 Million | ▼ -0.8 pp |
| 2021 | 97.2% | CA$31.55 Million | CA$874.03K | CA$37.17 Million | ▲ +1.0 pp |
| 2020 | 96.2% | CA$26.80 Million | CA$1.01 Million | CA$33.57 Million | ▲ +0.2 pp |
| 2019 | 96.0% | CA$25.79 Million | CA$1.02 Million | CA$30.97 Million | ▲ +3.1 pp |
| 2018 | 93.0% | CA$27.61 Million | CA$1.94 Million | CA$31.19 Million | ▲ +0.5 pp |
| 2017 | 92.5% | CA$22.21 Million | CA$1.67 Million | CA$25.10 Million | ▲ +0.1 pp |
| 2016 | 92.4% | CA$16.73 Million | CA$1.28 Million | CA$19.25 Million | ▲ +1.2 pp |
| 2015 | 91.1% | CA$12.15 Million | CA$1.08 Million | CA$14.61 Million | ▼ -8.1 pp |
| 2014 | 99.2% | CA$8.16 Million | CA$66.72K | CA$10.64 Million | ▲ +0.3 pp |
| 2013 | 98.9% | CA$4.85 Million | CA$52.99K | CA$6.09 Million | ▼ -1.1 pp |
| 2012 | 100.0% | CA$2.84 Million | CA$0.00 | CA$3.65 Million | ▲ +0.4 pp |
| 2011 | 99.6% | CA$1.16 Million | CA$4.39K | CA$1.58 Million | ▲ +0.1 pp |
| 2010 | 99.5% | CA$671.02K | CA$3.51K | CA$927.19K | ▲ +0.6 pp |
| 2009 | 98.9% | CA$607.02K | CA$6.87K | CA$747.73K | ▼ -1.1 pp |
| 2008 | 100.0% | CA$854.08K | CA$0.00 | CA$1.14 Million | ▲ +0.5 pp |
| 2007 | 99.5% | CA$1.12 Million | CA$5.54K | CA$1.31 Million | ▲ +0.1 pp |
| 2006 | 99.4% | CA$1.23 Million | CA$6.83K | CA$1.45 Million | ▼ -0.6 pp |
| 2005 | 100.0% | CA$811.46K | CA$0.00 | CA$1.02 Million | ▲ +0.0 pp |
| 2004 | 100.0% | CA$306.20K | CA$0.00 | CA$618.92K | ▲ +0.0 pp |
| 2003 | 100.0% | CA$606.86K | CA$0.00 | CA$773.39K | ▲ +16.4 pp |
| 2002 | 83.6% | CA$621.73K | CA$101.96K | CA$725.95K | ▲ +7.5 pp |
| 2001 | 76.1% | CA$990.86K | CA$237.07K | CA$2.26 Million | ▼ -23.9 pp |
| 2000 | 100.0% | CA$210.36K | CA$0.00 | CA$1.17 Million | ▲ +50.0 pp |
| 1999 | 50.0% | CA$600.00K | CA$300.00K | CA$1.40 Million | ▼ -22.7 pp |
| 1998 | 72.7% | CA$1.10 Million | CA$300.00K | CA$1.60 Million | ▲ +32.7 pp |
| 1997 | 40.0% | CA$500.00K | CA$300.00K | CA$1.10 Million | — |